Download PDF
Thromb Haemost 1985; 54(03): 730
DOI: 10.1055/s-0038-1660113
Letter to the Editor
Schattauer GmbH Stuttgart

Fibrinolysis in Degos’ Disease

J A Páramo
1   Service of Hematology, University Clinic of Navarra, Spain
,
E Rocha
1   Service of Hematology, University Clinic of Navarra, Spain
,
B Cuesta
1   Service of Hematology, University Clinic of Navarra, Spain
,
J M Arejola
2   Dept. of Internal Medicine, University Clinic of Navarra, Spain
,
M Montejo
3   Hospital Cruces de Bilbao, Spain
,
J Aguirre
3   Hospital Cruces de Bilbao, Spain
,
J Prieto
2   Dept. of Internal Medicine, University Clinic of Navarra, Spain
,
E Rocha Hernando Dr.
Service of Hematology, University Clinic of Navarra, Avda. Pío XII s/n Apartado 192, 318080-Pamplona, Spain
› Author Affiliations
Further Information

Publication History

Received 03 June 1985

Accepted 29 July 1985

Publication Date:
19 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Black MM, Nishioka K, Levene GM. The role of dermal blood vessels in the pathogenesis of malignant atrophic papulosis (Degos’ disease). A study of two cases using enzyme histochemical, fibrinolytic, electron-microscopal and immunological techniques. Br J Dermatol 1973; 88: 213-219
    CrossrefPubMedGoogle Scholar
  • 2 Colucci M, Paramo JA, Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985; 75: 818-824
    CrossrefPubMedGoogle Scholar
  • 3 Delaney TJ, Black MM. Effect of fibrinolytic treatment in malignant atrophic papulosis. Br Med J 1975; 3: 415
    PubMedGoogle Scholar
  • 4 Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436
    CrossrefPubMedGoogle Scholar